Q&A with DTRN Patient Jazmyn Morris Were thrilled to be able to share the perspective of someone whos actually experienced CoolSculpting after having three babies by C-section
The compound is the same synthetic triple receptor agonist at GIPR, GLP-1R and GCGR across every vial size, molecular formula CHNO, molecular weight 4731.3 g/mol, CAS 2381089-83-2
[1] [2] Native GLP-1 is broken down within minutes by an enzyme called DPP-4, which is precisely why pharmaceutical GLP-1 receptor agonists were engineered to resist that breakdown and last far longer
Only 5% to 10% of patients discontinue treatment due to side effects
The New England Journal of Medicine , 10.1056/NEJMoa2511774
It can allow for more gradual escalation of doses when starting treatment and reduce the GI side effects that most commonly occur during this period, says Kushner